Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

NCT06261918 ·Status: RECRUITING

A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients

NCT06257888 ·Status: COMPLETED

Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes

NCT04403984 ·Status: UNKNOWN

Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment

NCT02326857 ·Status: COMPLETED

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

NCT05809128 ·Status: UNKNOWN

Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET

NCT02261389 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer

NCT01791829 ·Status: ACTIVE_NOT_RECRUITING

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

NCT04365790 ·Status: UNKNOWN

Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

NCT05817227 ·Status: RECRUITING

Identification of New Prognostic Markers for Breast Cancer.

NCT03436069 ·Status: RECRUITING

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

NCT04145947 ·Status: UNKNOWN

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer

NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

NCT06591039 ·Status: RECRUITING

Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia

NCT05050890 ·Status: UNKNOWN

Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery

NCT04145973 ·Status: UNKNOWN

InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2

NCT05835739 ·Status: RECRUITING

Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer

NCT02670668 ·Status: UNKNOWN ·Phase: NA

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer

NCT04145960 ·Status: UNKNOWN

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

NCT04902937 ·Status: RECRUITING

BRCA and NACT in TNBC Patients

NCT05750719 ·Status: COMPLETED

International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study

NCT03078036 ·Status: COMPLETED

PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women

NCT03144648 ·Status: RECRUITING

Study in Patients With Breast Cancer Leptomeningeal Metastasis

NCT06638294 ·Status: RECRUITING

Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study.

NCT06026631 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

BRCA Mutation Carriers' Platform a Multicenter Study

NCT07253051 ·Status: RECRUITING